Pseudomonas aeruginosa, Acinetobacter spp. and Klebsiella spp. are three of the pathogens most frequently involved in infections of cancer patients, and the production of b-lactamases is a major mechanism of resistance due to its wide diversity of existing enzymes. Therefore, the aim of the present study was to investigate the microbiological profile and data related to patients and infections, and to search for b-lactamase genes in bacterial isolates from hospitalized cancer patients in a hospital in Recife, Pernambuco, Brazil. A total of 169 isolates were recovered between 2012 and 2014, of which 58 were P. aeruginosa, 36 were Acinetobacter spp. and 75 were Klebsiella spp. A high percentage of carbapenem resistance was observed in P. aeruginosa and Acinetobacter spp. Among the carbapenem-resistant bacteria, the bla SPM-1 gene was detected in P. aeruginosa (35.5 %) and Acinetobacter spp. (3.8 %), while bla KPC was detected in P. aeruginosa (25.8 %) only. Among the third-and fourth-generation cephalosporin-resistant strains, in Klebsiella spp. we detected the genes bla TEM (30.6 %), bla CTX-M (58.3 %) and bla KPC (5.6 %), and in Acinetobacter spp. only bla TEM (25.9 %). This the first report of an Acinetobacter baumannii bla SPM-1 gene carrier that has been isolated in Brazil. The most frequent cancer types were bowel tumour [14.8 %; 95 % confidence interval (CI 95 % ) 9.8-21.1 %], breast cancer (13.6 %; CI 95 % 8.8-19.7 %) and prostate cancer (11.2%; CI 95 % 6.9-17.0 %). These results therefore provide knowledge of susceptibility profile and resistance mechanisms and thus can contribute to the strategic formulation of hospital infection control plans and the rational use of antimicrobials, reducing mortality from infection levels in cancer patients. frequency and severity of infections may be related to the use of potent cytotoxic drugs and increasingly invasive diagnostic tools (Maschmeyer & Haas, 2008; Wang et al., 2011) .
INTRODUCTION
Bacterial infections have been indicated as a significant cause of mortality and morbidity among cancer patients, with or without neutropenia, despite advances in antibiotic therapy in recent decades (Wang et al., 2011; Pongas et al., 2012) . The frequency and severity of infections may be related to the use of potent cytotoxic drugs and increasingly invasive diagnostic tools (Maschmeyer & Haas, 2008; Wang et al., 2011) .
Given this vulnerability among patients with cancer, this population is more susceptible to community and healthcare-associated infections (HAIs). According to a recent survey by the Centers for Disease Control and Prevention (CDC), one in 25 hospitalized patients [4.0 %; 95 % confidence interval (CI 95 % ), 3.7-4.4] is battling an HAI, defined as those infections acquired in hospital or healthcare service unit that first appear 48 h or more after hospital admission or within 30 days after discharge following in-patient care (Revelas, 2012; Magill et al., 2014) . Other causes for concern in many healthcare centres for patients with cancer are the high bacterial resistance rates and the rise of opportunistic multidrug-resistant (MDR) pathogens such as Pseudomonas aeruginosa and Acinetobacter baumannii (Pongas et al., 2012; Fukuta et al., 2013; Marín et al., 2014) .
Gram-positive bacteria are described as the most frequent cause of HAIs in cancer patients, especially through bloodstream infection (Wisplinghoff et al., 2003; Maschmeyer & Haas, 2008; Wang et al., 2011; Kosmidis & Chandrasekar, 2012) , although in recent years a change in the epidemiology of infections in this group of patients has been observed, with an increase in infections caused by Gram-negative bacteria, and increased antibiotic resistance in this group of bacteria (Bassetti & Righi, 2013; Gudiol et al., 2010; Montassier et al., 2013; Marín et al., 2014) . The Gram-negative bacteria most frequently isolated in cancer patients are the Enterobacteriaceae Escherichia coli and Klebsiella spp., followed by the glucose non-fermenting bacilli P. aeruginosa, Acinetobacter spp. and Stenotrophomonas maltophilia (Wang et al., 2011; Bassetti & Righi, 2013; Marín et al., 2014) . In this group of bacteria, production of b-lactamases has been identified as a major cause of MDR, because of the wide diversity of enzymes, including extended-spectrum blactamases (ESBLs) such as TEM, SHV and CTX-M, and carbapenemases such as GES, Klebsiella pneumoniae carbapenemase (KPC) and metallo-b-lactamase (MBL) (Wang et al., 2011; Bassetti & Righi, 2013; Chaudhary & Payasi, 2014; Zafer et al., 2014) .
Thus, study of the resistance profile and frequency of isolated b-lactamase producers is important for an understanding of the epidemiology of HAIs and to recommend and adopt appropriate preventive and control measures. Therefore, the present study aimed to investigate the microbiological profile and data related to patients and infections, and search for the bla SPM-1 , bla IMP , bla VIM , bla KPC , bla TEM and bla CTX-M genes in bacterial isolates from cancer patients admitted to a hospital in Recife, state of Pernambuco, Brazil, between November 2012 and April 2014.
METHODS
Collection and identification of bacterial isolates. Pseudomonas aeruginosa, Acinetobacter spp. and Klebsiella spp. were collected from November 2012 to April 2014, from patients with solid cancer, admitted to a hospital specializing in the care of cancer patients located in Recife.
The samples were collected by hospital staff and sent to an outsourced laboratory (Centro Integrado de An alises Clínicas -CIAC) for isolation, identification and antimicrobial susceptibility testing. Species identification was performed using standard microbiological techniques (Winn et al., 2008) and antimicrobial susceptibility testing was performed by the disc diffusion test and followed standard guidelines (CLSI, 2014) . The strains were then provided for analysis and kept frozen in 20 % glycerol at À20
C for subsequent analysis.
Sample characterization. The sample type and site of hospitalization were collected from the results of microbiological tests and the type of solid tumour from medical records.
Extraction and quantification of DNA. The total DNA of carbapenem-or third-and fourth-generation cephalosporin-resistant strains was extracted. This was done using a Brazol DNA extraction kit (LGC Biotechnology) according to the protocol provided by the manufacturer, and the measurement thereof was performed by spectrophotometry (Ultraspec 3000; Pharmacia Biotech) over the wavelength range 260-280 nm.
were investigated in third-and fourth-generation cephalosporin-resistant strains and carbapenem-resistant strains. MBL genes (bla SPM-1 , bla IMP , bla VIM ) and bla KPC were investigated using specific primers (Table 1 ) (Rasheed et al., 2000; Yigit et al., 2001; Saladin et al., 2002; Gales et al., 2003; Dong et al., 2008) . These genes were investigated in Pseudomonas aeruginosa, Acinetobacter spp. and Klebsiella spp. strains, except the bla CTX-M gene, the study of which was performed only in isolates of Klebsiella spp., as it is the most frequent type of MBL gene. Also in Klebsiella spp., the bla KPC gene was investigated in third-and fourthgeneration cephalosporin-resistant strains, because carbapenem resistance cannot be detected by conventional assays in vitro in Klebsiella spp. producing KPC (Pfeifer et al., 2010) .
For each gene the amplification reactions were performed in a total volume of 25 µl per tube, as detailed below.
b-Lactamase group TEM, CTX-M and KPC. For the bla TEM and bla CTX-M genes, 10 ng genomic DNA was used, and for the bla KPC gene 5 ng of the same was used. A total of 25 pmol primers (Table 1) , 1Â buffer, 200 µM dNTP (Ludwig Biotec), 1.5 mM MgCl 2 and 2.0 U Taq DNA polymerase (Promega) were added (Rasheed et al., 2000; Yigit et al., 2001; Saladin et al., 2002) .
Metallo-b-lactamases. For the bla SPM-1 , bla IMP and bla VIM genes, 25 ng genomic DNA, 10 pmol primers (Table 1) , 1Â buffer, 100 µM dNTP (Ludwig Biotec), 1.5 mM MgCl 2 and 1.0 U Taq DNA polymerase (Promega) were used (Gales et al., 2003; Dong et al., 2008) .
PCR amplification was performed in a thermocycler (Biosystems) as follows: initial denaturation at 95 C for 5 min followed by 30 cycles (bla SPM-1 , bla IMP , bla VIM ) or 35 cycles (bla TEM , bla CTX-M , bla KPC ) of denaturation at 95 C for 1 min, annealing according to the temperature described in Table 1 for 1 min, and extension at 72 C for 1 min, and then a final extension of 10 min at 72 C (Rasheed et al., 2000; Yigit et al., 2001; Saladin et al., 2002; Gales et al., 2003; Dong et al., 2008) .
The PCR products were stained with blue dye (Jena Bioscience) and subjected to electrophoresis on 1.0 % agarose gels in a TBE buffer (0.089 M Tris-borate, 0.002 M EDTA) under a constant voltage of 100 V, visualized under UV light and documented photographically.
For each PCR, a negative control was included, consisting of reaction components and no added template DNA, and positive control strains for the genes: bla SPM-1 (P. aeruginosa PSA319), bla IMP (P. aeruginosa 48-1997A) and bla VIM (P. aeruginosa VIM-1) supplied by the Laboratório Alerta, Universidade Federal de São Paulo (UNIFESP); bla KPC (P. aeruginosa P22A), bla CTX-MA (Enterobacter cloacae Ec1A) and bla TEM (P. aeruginosa P14HC), from the culture collection of the Laboratório de Bacteriologia e Biologia Molecular, Departamento de Medicina Tropical, Universidade Federal de Pernambuco (UFPE). C for 3 min, followed by 30 cycles of denaturation at 92 C for 1 min, annealing at 36 C for 1 min and extension at 72 C for 8 min, followed by a final extension of at 72 C for 16 min (Duan et al., 2009) . PCR products were stained with green dye (Jena Bioscience) and subjected to electrophoresis on agarose gel to 1.5 % in a TBE buffer under a constant voltage of 100 V. The band patterns generated by ERIC-PCR were analysed in accordance with Tenover et al. (1995) .
RESULTS

Sample characterization
From November 2012 to April 2014, 169 isolates were collected and included in the search criteria, of which 75 were Klebsiella spp. (44.4 %; CI 95 % 36.8-52.2 %), 58 were P.aeruginosa (34.3 %; CI 95 % 27.2-42.0 %) and 36 were Acinetobacter spp. (21.3 %; CI 95 % 15.4-28.3 %). These isolates were obtained from 107 patients with solid cancer, admitted to a hospital specializing in the care of patients with cancer located in Recife. Although the percentage of Klebsiella spp. was higher than the percentage of Acinetobacter spp., there was no significant difference in the characteristics related to sample type, site of hospitalization or type of solid tumour among the three investigated pathogens.
The most frequent samples were tracheal aspirate (37.9 %; CI 95 % 30.5-45.6 %), blood culture (20.1 %; CI 95 % 14.4-27.0 %) and urine culture (12.4 %; CI 95 % 7.9-18.4 %), and more than half of the patients were admitted to the intensive care unit (ICU) (63.2 %; CI 95 % 56.2-71.1 %), which is a risk factor for infections caused by MDR pathogens (Table 2) .
When analysing the cancer types, grouping the clinical isolates of the study together, the most frequent were bowel tumour (14.8 %; CI 95 % 9.8-21.1 %), breast cancer (13.6 %; CI 95 % 8.8-19.7 %) and prostate cancer (11.2 %; CI 95 % 6.9-17.0 %). However, there was little variation in the sequence of presumptive diagnosis in order of magnitude between bacteria. Thus, the most common malignancies were breast cancer (17.2 %; CI 95 % 8.6-29.4 %), laryngeal cancer (17.2 %; CI 95 % 8.6-29.4 %) and colon cancer (13.8 %; CI 95 % 6.2-25.4 %) for P. aeruginosa, prostate cancer (22.2 %; CI 95 % 10.1-39.1 %), breast cancer (19.4 %; CI 95 % 8.2-36.0 %) and colon cancer (16.1 %; CI 95 % 6.4-32.8 %) for Acinetobacter spp., and bowel cancer (14.7 %; CI 95 % 7.6-24.7 %), prostate cancer (13.3 %; CI 95 % 6.6-23.2 %) and stomach cancer (9.3 %; CI 95 % 3.8-18.3 %) for Klebsiella spp. (Table 2) .
Antimicrobial susceptibility profile
The antimicrobial susceptibility profile showed that Acinetobacter spp. had the highest percentage of antimicrobial resistance, while Klebsiella spp. presented the highest percentages of antimicrobial susceptibility. A high percentage of carbapenem resistance was also noted in both P. aeruginosa (53.4 %) and Acinetobacter spp. (66.7 %). However, in Klebsiella spp., carbapenems were the class of antimicrobials with the highest sensitivity percentage, demonstrating that they remain an effective therapeutic option for this bacterial group (Table 3) .
In general, the class of antimicrobials whose bacteria had a higher percentage of sensitivity were aminoglycosides, ranging from 55.2 % in P. aeruginosa to 84.4 % in Klebsiella spp., when amikacin was used (Table 3) .
Analysing the greatest percentage of bacterial resistance, 53.4 % of P. aeruginosa strains were resistant to imipenem and to meropenem. For the Acinetobacter spp. strain, the greatest antimicrobial resistance was detected in et al. (2002) ciprofloxacin (77.8 %), ceftriaxone (75.0 %) and ceftazidime (72.2 %); and for the Klebsiella spp. strains, in ampicillin (88.3 %) and ceftriaxone (51.9 %) (Table 3) .
Regarding MDR rates, 58.6 % of P. aeruginosa, 77.8 % of Acinetobacter spp. and 64.0 % of Klebsiella spp. were MDR.
PCR of b-lactamase genes
The research strains for b-lactamase genes were selected from the criteria described in the Methods and the results obtained are shown in Table 4 .
The bla SPM-1 gene was detected in 11 isolates of P. aeruginosa (35.5 %) and one of Acinetobacter baumannii (3.8 %), with the latter being the first case of positivity for this gene in bacteria of the genus Acinetobacter in Brazil. The amplicon was sequenced and the sequence of the encoded protein was determined using BLAST (http://blast.ncbi.nlm.nih.gov/ Blast.cgi) and CLUSTAL W (http://www.cbi.ac.uk/). These analyses confirmed that the amplified gene was bla SPM-1 (GenBank accession no. KR185964). No isolate was positive for the bla IMP and bla VIM genes (Table 4 ).
The bla KPC gene was also amplified in eight isolates of P. aeruginosa (25.8 %), of which one strain presented bla SPM-1 and bla KPC genes concomitantly. In Klebsiella spp., the KPC gene was identified in only 5.6 % of isolates resistant to carbapenems and third-and fourth-generation cephalosporins (Table 4) .
For the other b-lactamase gene, bla TEM was identified in seven isolates of Acinetobacter spp. (25.9 %) and 11 isolates of Klebsiella spp. (30.6 %), but was not amplified in P. aeruginosa from the hospital. The bla CTX-M gene had the highest molecular frequency in the study, with 21 Klebsiella spp. positive strains, which represented 58.3 % of the bacteria analysed for this gene (Table 4) . Of 11 Klebsiella spp. bla-TEM -positive strains, eight also presented the bla CTX-M gene concomitantly.
Molecular typing
Molecular typing was performed only in MDR isolates, with 30 P. aeruginosa, 30 Acinetobacter spp. and 39 Klebsiella spp. Twenty-one different profiles were identified for P. aeruginosa, with three of these being considered clonal profiles with a similarity of 100 %. The other profiles had similarities ranging from 4 to 40 %. For Acinetobacter spp., 17 different profiles were identified, five of which were considered clones, with one predominant clone whose profile was identified in 10 isolates. The other profiles had similarities ranging from 4 to 60 %. For Klebsiella spp., 35 different profiles were detected, with three clonal profiles and other similarities ranging from 5 to 75 %.
DISCUSSION
In the present study, we investigated 169 clinical isolates of Klebsiella spp., P. aeruginosa and Acinetobacter spp. Although slight variations were found in their order of incidence, these three pathogens were among the top five causes of infection in cancer and non-cancer patients (Pongas et al., 2012; Ram et al., 2012; Chaudhary & Payasi, 2014; Andria et al., 2015) . The persistence of these bacteria in the hospital environment may be related to the high degree of MDR or even the production of virulence factors such as biofilm production (Murray et al., 2009 ).
In terms of clinical sample types, tracheal aspirates were the most frequent in the present study, followed by blood and urine. In the Chaudhary & Payasi (2014) study, blood samples were also the second most frequent clinical material.
Although not always the first cause of HAIs, many studies have focused on the association between bloodstream infection and high morbidity and mortality, either directly or by interfering with the chemotherapy schedule, which makes examination of blood culture important for prediction of infection (Paul et al., 2010; Araujo, 2012; Miedema et al., 2013; Moghnieh et al., 2015) .
Regarding cancer types, the results of the present study corroborated the data from the Hospital Information System of the Brazilian Unified National Health System (SIH-SUS), whose analysis of cancer hospitalization statistics in the state of Pernambuco (target population) revealed that the most common types among the patients included in the present study matched the cause of hospitalization in the same location and study period (Minist erio da Saúde Brasil, 2015).
When comparing the frequency of MDR strains in this study with others carried out with non-cancer patients admitted to hospitals in Recife, similar MDR percentages were found by J acome et al. Among the carbapenem-and ceftazidime-resistant strains, the present study found that 35.5 % of P. aeruginosa exhibited the bla SPM-1 gene. For hospitals in the same city, J acome et al. (2012a) detected a lower frequency of 20.7 % of isolates resistant to carbapenems and ceftazidime, and 46.2 % when only phenotypically MBL-positive strains were considered. Cavalcanti et al. (2012) , for another university hospital located in Recife, identified a higher percentage of the bla SPM-1 gene (83.6 %) in the imipenem-and ceftazidime-resistant P. aeruginosa strains investigated. This variation observed between studies may be related to the fact that each was performed in different hospitals. Figueiredo et al. (2007) analysed two hospitals located in Recife, and observed significant differences in the antimicrobial susceptibility profiles of P. aeruginosa, which they attributed to differences in the customer profile at each institution and their participation in the Infection Control Practices Advisory Committee (ICPAC). This difference between institutions reinforces the importance of studying the microflora and resistance profile of each hospital, even when these are located in the same municipality (Figueiredo et al., 2007) .
Studies performed in a paediatric hospital in São Paulo detected the bla SPM-1 gene in 33.3-56.3 % of cancer patients (Fernandes et al., 2010; Quiles et al., 2015) . These results indicate the occurrence of SPM-1-positive P. aeruginosa in Brazilian hospital settings, and that this gene remains frequent.
With regard to the identification of the bla SPM-1 gene in Acinetobacter spp., this was the first such case in Brazil. This gene is associated with a single clone (SP/ST 277) of P. aeruginosa, and while its dissemination is almost totally restricted to Brazil (Gonz alez et al., 2014) , there are a few reports of it in other countries such as Switzerland (Salabi et al., 2010 ), Mexico (Quinones-Falconi et al., 2010 , South Korea (Lee et al., 2012) and Iran (Ghamgosha et al., 2014) , all linked to P. aeruginosa. In A. baumannii, only one case has been described in Iran, from which the gene was sequenced and deposited in GenBank, and proved to be the bla SPM-1 gene (Shahcheraghi et al., 2011) .
In the present study, the bla KPC gene was amplified from 25.8 % of P. aeruginosa, and the data indicate that this gene is still circulating in hospital in Recife. Despite the bla KPC gene being rarely detected in P. aeruginosa (Zafer et al., 2014) , it is important to note that the first identification of the bla KPC gene in P. aeruginosa in Brazil occurred in a public hospital in Recife (J acome et al., 2012b) , the same city as this study.
Among strains of Klebsiella spp. resistant to carbapenems, none carried the bla KPC gene. When third-and fourth-generation cephalosporin-resistant strains were included, we found that 5.6 % of Klebsiella spp. were bla KPC -positive. This result corroborates findings that report the possible failure to detect carbapenem resistance in vitro using conventional tests in KPC-producing strains (Pfeifer et al., 2010) . Other studies conducted in Recife hospitals with non-cancer patients, showed a higher frequency of K. pneumoniae isolates that were resistant to carbapenems, as well as a strain carrying the bla KPC gene (Cabral et al., 2012; de Melo et al., 2014) .
Regarding other b-lactamases, the bla TEM gene was identified in 25.9 % of Acinetobacter spp. and 30.6 % of Klebsiella spp., and the bla CTX-M gene in 58.3 % of Klebsiella spp. Studies in other populations and different countries indicate a lower percentage of these enzymes in the same pathogens (AL-Thahab, 2013; Chaudhary & Payasi, 2014) . This matches data from the Guzman-Blanco et al. (2014) study, which found that the rate of nosocomial infections caused by extended-spectrum b-lactamases in Brazil is one of the largest in the world.
It is also interesting to note the identification of MRD clones and carriers of b-lactamase genes in different hospital sectors (data not shown), pointing to the risk of spread of these pathogens in the hospital. The application of molecular typing techniques in sample hospitals allows the dynamics of transmission of infections to be mapped, leading to a more targeted application of infection control measures at the local level (Hafiane & Ravaoarinoro, 2008) .
Additionally, joint implementation of effective measures for infection control, microbiological monitoring and surveillance of antimicrobial resistance patterns is of the utmost importance to reducing the morbidity and mortality rates caused by bacterial infections, and lowering hospital costs (Vasudevan et al., 2015) . This study presents the molecular epidemiological situation of b-lactamases in a hospital specializing in cancer patients and reinforces the importance of continuous monitoring of these pathogens in the hospital environment. 
